Key Takeaways
- Sulfur price spike crushed EBITDA: Q2 EBITDA collapsed to ₹11.6 crores as sulfur prices hit levels that triggered global demand destruction, making sulfuric acid unsellable at cost-recovery prices.
- Speciality traction masked by commodity chaos: The Speciality Chemicals business saw "pretty good traction" with overseas recovery and new country entries, but this was completely overshadowed by sulfur price volatility in reported results.
- Normalized sulfur reveals the real split: At pre-war sulfur prices (~$500/ton), the Speciality revenue split would already be "very close to 50-50," indicating the strategic target is effectively met on a normalized basis.
- Europe declared structurally dead: Management believes the European chemical industry decline is structural, not cyclical, and does not expect great growth from there anymore; Latin America and Asia are filling the gap at similar margins.
- What to watch next quarter: Whether sulfur price softening actually restores sulfuric acid demand and fertilizer offtake, the ramp of the new oil-recovery product toward its ₹25–50 crore annualized run-rate, and any progress on Korean market entry.
Sulfur Shock: What Broke This Quarter
- Demand destruction mechanism: Sulfur prices rose so high that sulfuric acid made from it crossed a threshold (~₹30,000/ton equivalent) where end-use markets globally stopped buying; this was confirmed at a recent industry conference as a worldwide phenomenon, not just an India issue.
- Pass-through failed: In Q1, the company passed sulfur price increases through to customers; in Q2, prices reached levels where passing through was impossible because demand simply vanished.
- Fertilizer sector cracked first: GSFC shut down fertilizer operations and dumped sulfuric acid into the market at low prices; detergents and other downstream chemicals also reduced production, compounding the oversupply.
- Deliberate low utilization: The company ran the acid plant at ~65% capacity, only enough to supply utilities to downstream specialty plants; selling additional volumes below cost made no commercial sense. A complete shutdown would have raised Speciality Chemical costs by an estimated 10%.
- Inventory gain reversal: Q1 margins benefited from selling sulfuric acid at higher prices while holding lower-cost sulfur inventory; management had flagged this could not continue, and those gains reversed in Q2.
- Working capital strain: Higher raw material prices and increased receivables from higher topline pushed working capital up; interest costs doubled YoY mainly because topline growth required more working capital, though banks have been supportive.
Goculdas: "The whole thing was overshadowed by the sulfur price and I in fact recently attended a conference on sulfur and sulfuric acid, and it was sort of reassuring to see that it was not only India which was affected, but also globally, there was demand destruction."
Speciality Chemicals: The Hidden Progress
- Overseas recovery underway: The Speciality Chemical business had "pretty good traction" with recovery in overseas markets and entry into new countries; exports in absolute numbers were better than both the previous quarter and the previous year.
- Geographic pivot from Europe: Management personally believes Europe's chemical industry decline is structural, driven by energy costs and integration failures; Latin America and Japan have seen good success, and the Korean market is being explored with developments expected "hopefully soon."
- Margins held in new markets: Latin American and Asian orders replacing European business carry similar margins; the company is not giving up quality to hold volumes.
- India growth expected: Good growth is anticipated in the Speciality Chemicals area within India.
- New oil-recovery product commercialized: Started commercial sales of an intermediate for a polymer used in enhanced oil recovery; product has been approved and serves multiple customers; expected annualized revenue of ₹25–50 crores, entering from a zero base and taking market share from incumbents.
- Boron Speciality pipeline: Two products in development in the fine chemical space, one for catalytic application and one as an agrochemical intermediate; both developing well with margin profiles expected to be "substantially better" than existing products.
- Product approval cycles cleared: Time lag existed for Asian and Latin American customers (sophisticated end users, multinational companies), but "we are past that now for most of the countries."
Goculdas: "If you go back to the pre-war levels, you put sulfur back to $500 per ton. Okay, then we'll be very close to 50-50. Okay, so we are at that level already. Unfortunately, this whole, this war situation has completely skewed the numbers."
Sulfuric Acid: The Commodity Anchor
- Business was negative for the quarter: Management confirmed sulfuric acid as a standalone business lost money in Q2; everyone across the industry also operated at low capacities, but nobody has actually exited.
- Integration logic holds: The acid plant was not shut down because it supplies utilities to downstream specialty plants; running it at minimum levels avoided an estimated 10% cost increase on Speciality Chemicals that a full shutdown would have caused.
- Fertilizer demand expected back: Post-October, the situation is easing slowly; management expects fertilizer demand to return because "you can't keep fertilizer plants shut down because fertilizer is needed in the country."
- Sulfur market turning: Prices are softening and availability is easing from the $1,100–$1,200 peak; as prices come off, demand is expected to increase again, and some of that increase has already been seen.
Goculdas: "I think we have been through the worst of it. And I think now prices are softening and availability is also easing. Hopefully, nothing flares up again."
Europe: Structural Decline Thesis
- Not cyclical, structural: Management personally believes the European chemical industry decline is a structural problem driven by energy costs and integration failures; does not expect great growth from Europe anymore.
- Destruction has played out: Whatever destruction was to happen in Europe has already happened; the company is not waiting for a recovery there.
- Replacement markets identified: Latin America and Japan have delivered good success; Korea is the next target; within India, good growth is expected in Speciality Chemicals.
- Margin quality preserved: Orders replacing European business in Latin America and Asia carry similar margins; the company is not discounting to hold volumes.
Goculdas: "I personally believe that it is a structural problem in Europe. I do not see that coming back. I think there are too many issues with their energy cost and too many issues on their whole integration sort of falling apart."
Capacity, R&D & New Products
- Significant capacity headroom: At least 25% to 30% room to expand across different downstream products; some expansion is possible with very low CAPEX without putting up an entirely new plant, unless pursuing an entirely new product.
- R&D spend increasing: Confirmed R&D spending will go up; "you will see that shortly, that is on course"; currently all R&D expenditure is directed toward new product development.
- Oil-recovery product ramp: Newly commercialized intermediate for enhanced oil recovery polymer; expected annualized revenue of ₹25–50 crores; entering from a zero base and will take market share from incumbents; demand tied to crude pumping volumes, which management expects will persist regardless of price cycles.
- Boron fine chemicals advancing: Two products in development, one for catalytic application and one as an agrochemical intermediate; margin profile expected to be "substantially better" than existing products.
- DCDPS deprioritized: Not a focus at the moment.
Balance Sheet & Financing
- Working capital increased: Driven by higher raw material prices (sulfur) and increased receivables due to higher topline.
- Interest cost doubled YoY: Mainly because topline growth required more working capital; banks have been supportive and increased working capital limits; term loans are being repaid on schedule.
- Sulfur inventory norms: Typical sulfur stock held is 15–20 days maximum across Roha and Dahej plants; exact current holding was not available offhand.
- Land monetization stalled: The Supreme Court has given an order on the Amarnath land but the Maharashtra government has not complied; a survey is ongoing; timeline is "very tough to say" and the company will "have to just wait for it."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Sulfur price normalization | Prices softening from $1,100–$1,200 peak; demand expected to increase as prices come off | Already seeing some increase |
| Fertilizer demand recovery | Fertilizer plants cannot stay shut indefinitely; demand expected to return | Post-October easing slowly |
| New oil-recovery product revenue | Annualized revenue of ₹25–50 crores, entering from zero base | Ramp underway, no end-date |
| R&D spend increase | R&D spending will go up, all directed at new product development | "You will see that shortly" |
| Korean market entry | Exploring the Korean market | "Hopefully soon" |
| Boron Speciality products | Two products in fine chemical space; margin profile "substantially better" than existing | In development, no timeline |
| Land monetization (Amarnath) | Supreme Court order issued; Maharashtra government non-compliant; survey ongoing | "Very tough to say" |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | ₹273 cr |
| EBITDA | ₹11.6 cr, sharp drop from previous quarter |
| EBITDA margin | 4%, down from 13.5% in Q1 FY27 (per an analyst's math) |
| H1 FY27 revenue | ~₹525 cr (per an analyst's math) |
| H1 FY27 EBITDA margin | ~8% to 8.5% (per an analyst's math) |
| Sulfuric acid plant utilization | ~65% of capacity, down from 95–100% previously |
| Speciality revenue split | 27% of total revenue (per an analyst's math) |
| Exports share of revenue | ~12% (per an analyst's math) |
| Sulfur price (spot) | ~$800 per ton, down from peak of $1,100–$1,200 post-Iran crisis |
| Interest cost | Roughly doubled YoY, driven by short-term working capital borrowing |
| Working capital borrowing rate | 7.5% to 8.5% |
| Debtor days | Within 45 days |
| R&D expense | ~₹2 cr per annum |
| Headroom for expansion without major capex | At least 25% to 30% |
| New oil-recovery intermediate expected annualized revenue | ₹25–50 cr |